GST cut on health insurance premium deferred, cancer drugs to become cheaper

New Delhi: The GST Council, headed by Finance Minister Nirmala Sitharaman, on Monday announced setting up a Group of Ministers (GoM) on slashing the tax rate on life and health insurance, as well as reducing the GST on cancer drugs and ‘namkeens’ (selected snacks). The GoM on life and health insurance will be headed by Bihar Deputy Chief Minister Samrat Choudhary, who is currently heading the panel on GST rate rationalisation.

The 54th GST Council meeting reached a “broad consensus” to bring relief to individuals and senior citizens with a decision on the GST applied to health insurance premiums. The current GST rate on health and life insurance policies stands at 18 per cent. Meanwhile, the GST Council announced to reduce the GST rate on cancer drugs to 5 per cent from 12 per cent and on namkeens to 12 per cent from 18 per cent. The members also agreed to form a GoM on compensation cess.

“The GST Council has agreed to form a GoM which will now take it up to study and decide on how to move forward on compensation of cess which will cease after March 2026,” said FM Sitharaman. The total cess collection projected until March 2026 stands at Rs 8.66 lakh crore. After settling the loan payments, a projected surplus of around Rs 40,000 crore is expected. Revenue Secretary Sanjay Malhotra said that the GST compensation cess may be discontinued post-debt repayments.

At a press conference after the meeting, Malhotra also said import of services by foreign airline companies will be exempt from GST. Universities and research centres established by central or state government laws, or those granted income tax exemptions, will now be exempt from paying GST on research funding, said FM Sitharaman. The GST panel also decided to introduce business-to-customer (B2C) GST invoicing.

This new system for GST invoice management will take effect from October 1. It was also announced to surge GST on car seats from 18 per cent to 28 per cent.

Related Posts

Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

New Delhi — A disturbing series of medical negligence, quackery, and illegal drug practices has surfaced across Madhya Pradesh, Haryana, Uttar Pradesh, and Chhattisgarh in the past 48 hours, claiming…

Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

New Delhi — A relentless surge in seizures of codeine-based cough syrups and narcotic tablets across multiple states over the past 48-72 hours has laid bare the rampant diversion of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

TN, Karnataka, Rajasthan declare highest number of NSQs in January

TN, Karnataka, Rajasthan declare highest number of NSQs in January

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

CDSCO modifies norms for testing permissions to speed up drug approvals

CDSCO modifies norms for testing permissions to speed up drug approvals